Plasma donation in Budapest
Plasma donation at the University of Physical Education. Thirty volunteers, donors came forward and offered to help. https://www.youtube.com/watch?v=P2WQHbdRDGo
Albumin Bone Graft Patent Granted in the US – Important milestone in Lacerta’s IP strategy
Krems an der Donau, Austria, 4 September 2013 – The United States Patent Office has granted the patent entitled “Method for producing...
Lacerta announces positive results of double-blind controlled study on BoneAlbumin
At the International Conference ‘Unified Scientific Approaches towards Regenerative Orthopaedics and Dentistry’ in Venice, Italy, Dr. Lacza has announced the preliminary...
Lacerta Technologies is now OrthoSera
Krems an der Donau, Austria, 26 November 2015 – Lacerta Technologies, an orthobiologics company developing serum-based solutions for musculoskeletal indications has...
OrthoSera successfully closes financing round
Krems an der Donau, Austria, 4 December 2015 – Shortly after market launch of our first product BoneAlbumin via our...
BoneAlbumin induces better bone formation
Krems an der Donau, Austria, 29 June 2016 – OrthoSera GmbH, an orthobiologics company developing serum-based solutions for musculoskeletal indications...
OrthoSera Receives CE Mark for hypACT™ Device to Regenerate Osteoarthritic Bone
OrthoSera GmbH, an orthobiologics company developing serum-based solutions for musculoskeletal indications announces that its proprietary serum technology is ready for...
OrthoSera closes Series B financing round
hypACT™ serum therapy for the regeneration of osteoarthritic bone and cartilage is entering clinical development OrthoSera GmbH, an orthobiologics company...
Hyperacute Serum promotes stem cell and cartilage cell regeneration
Two peer-reviewed studies showed that hypACT outperforms PRP as a regenerative serum.Krems an der Donau, Austria, 15 January 2018 –...
OrthoSera presents positive results of hypACT™ in osteoarthritis
Hyperacute serum therapy: pilot first-in-man results in knee osteoarthritis Krems an der Donau, Austria, 25 September 2018 – OrthoSera GmbH,...
New R&D Project – Role of microvesicles in ostheoarthritis
THE ROLE OF MICROVESICLES FROM BLOOD PRODUCTS IN OSTEOARTHROSIS Krems an der Donau – OrthoSera GmbH joined to a special...
ICRS Focus Meeting imaging Vienna
OrthoSera is a proud silver sponsor of ICRS cartilage event located in Vienna from 21.-23.11.2019.